Authors’ Reply to the Letter by Shoar et al. on “Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo” - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Cardiology Année : 2020

Authors’ Reply to the Letter by Shoar et al. on “Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo”

Résumé

No abstract available
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée

Dates et versions

inserm-03090462 , version 1 (29-12-2020)

Identifiants

Citer

Pierre Ambrosi, Aurélie Daumas, Patrick Villani, Roch Giorgi. Authors’ Reply to the Letter by Shoar et al. on “Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo”. Cardiology, 2020, 145 (6), pp.387-387. ⟨10.1159/000507361⟩. ⟨inserm-03090462⟩
125 Consultations
3 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More